Cantitate/Preț
Produs

Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma: Liver Fluke Related Cholangiocarcinoma: Recent Results in Cancer Research, cartea 219

Editat de Narong Khuntikeo, Ross H. Andrews, Trevor N. Petney, Shahid A. Khan
en Limba Engleză Hardback – 4 sep 2023
This volume discusses new developments in the etiology, diagnosis, and treatment of cholangiocarcinoma induced by the liver fluke Opisthorchis viverrini. Although cholangiocarcinoma is rare in the Western world, it has a very high incidence in continental Southeast Asian countries, where it is linked to infection with O. viverrini. In Southeast Asia this cancer causes thousands of deaths every year and places a severe socioeconomic burden on the affected families. Diagnosis is usually at a late disease stage, and in the past palliative surgery and care have been the major therapeutic options. Recently, however, techniques have become available for early-stage diagnosis that offer the possibility of curative surgery, and novel chemotherapeutic options are also under development. In Thailand alone, more than 2 million individuals have now been registered for screening for this cancer. The aim of this book is to highlight the latest research in the field and to explain how the newly available techniques can be applied to reduce the risk of developing cholangiocarcinoma and increase the likelihood of survival.
Citește tot Restrânge

Din seria Recent Results in Cancer Research

Preț: 90064 lei

Preț vechi: 94803 lei
-5% Nou

Puncte Express: 1351

Preț estimativ în valută:
17236 17904$ 14317£

Carte disponibilă

Livrare economică 11-25 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783031351655
ISBN-10: 3031351657
Pagini: 367
Ilustrații: XII, 367 p. 166 illus., 110 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.77 kg
Ediția:1st ed. 2023
Editura: Springer International Publishing
Colecția Springer
Seria Recent Results in Cancer Research

Locul publicării:Cham, Switzerland

Cuprins

Introduction.- Liver flukes and cancer: epidemiology including other risk factors.- Carcinogenesis/Biochemistry.- Genetics.- Diagnosis.- New imaging techniques.- Pathology.- Surgery/Clinical.- Other treatment.- Palliative care.- Control options.- Digital innovations.

Notă biografică

Assoc. Prof. Narong Khuntikeo is the director and initiator of the Cholangiocarcinoma (CCA) Research Institute (CARI) and The Cholangiocarcinoma Screening and Care Program (CASCAP) at Khon Kaen University, Thailand. The institute and program aim to reduce the mortality caused by CCA by reducing the incidence of infection with the liver fluke Opisthorchis viverrini, the main risk factor for developing CCA, as well as developing new clinical approaches to early disease diagnosis, surgery and chemotherapy. To date over 600,000 at-risk individuals have been screened ba CASCAP to detect early stage disease.Prof. Khuntikeo received his MD at the Faculty of Medicine in Khon Kaen in 1984 and received a fellowship in Hepato-Pancreatic Biliary Surgery and Liver Transplantation at the Princess Alexandra Hospital, Brisbane in 1994. He is the recipient of numerous awards and extensive funding for his work on combatting CCA. Ross H Andrews and Trevor N Petney have done extensive work on O. viverrini including its systematics, genetic variability, host choice and transmission dynamics. Both are senior advisors at the Cholangiocarcinoma Research Institute, Khon Kaen University. Shahid A Khan is an internationally renowned liver specialist in biliary cancer.



Textul de pe ultima copertă

This volume discusses new developments in the etiology, diagnosis, and treatment of cholangiocarcinoma induced by the liver fluke Opisthorchis viverrini. Although cholangiocarcinoma is rare in the Western world, it has a very high incidence in continental Southeast Asian countries, where it is linked to infection with O. viverrini. In Southeast Asia this cancer causes thousands of deaths every year and places a severe socioeconomic burden on the affected families. Diagnosis is usually at a late disease stage, and in the past palliative surgery and care have been the major therapeutic options. Recently, however, techniques have become available for early-stage diagnosis that offer the possibility of curative surgery, and novel chemotherapeutic options are also under development. In Thailand alone, more than 2 million individuals have now been registered for screening for this cancer. The aim of this book is to highlight the latest research in the field and to explain how the newly available techniques can be applied to reduce the risk of developing cholangiocarcinoma and increase the likelihood of survival.

Caracteristici

Describes new developments in diagnosis and treatment of Cholangiocarcinoma Explains how the newly available techniques can be applied to reduce the risk of developing cholangiocarcinoma Written and edited by experts in the field